Liabilities, Current in USD of NovaBridge Biosciences from Q4 2019 to Q2 2025

Taxonomy & unit: us-gaap: USD and CNY
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: NovaBridge Biosciences quarterly Liabilities, Current history and change rate from Q4 2019 to Q2 2025.
NovaBridge Biosciences Liabilities, Current for the quarter ending 30 Jun 2025 was $7,347,000.
Source SEC data: View on sec.gov

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Change (%)

NovaBridge Biosciences Quarterly Liabilities, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2025	$7,347,000			30 Jun 2025	6-K	06 Oct 2025	2025	Q2
Q4 2024	$8,454,000	-$49,690,000	-85%	31 Dec 2024	6-K	06 Oct 2025	2025	Q2
Q4 2023	$58,144,000	-$51,779,000	-47%	31 Dec 2023	20-F	03 Apr 2025	2024	FY
Q4 2022	$109,923,000	+$12,003,000	+12%	31 Dec 2022	20-F	01 May 2023	2022	FY
Q2 2022	$88,085,000			30 Jun 2022	6-K	10 Nov 2022	2022	Q2
Q4 2021	$97,920,000	+$9,625,000	+11%	31 Dec 2021	20-F	29 Apr 2022	2021	FY
Q4 2020	$88,295,000	+$3,766,000	+4.5%	31 Dec 2020	20-F	28 Apr 2021	2020	FY
Q3 2020	$51,460,000			30 Sep 2020	6-K	05 Feb 2021	2020	Q3
Q4 2019	$84,529,000			31 Dec 2019	20-F	29 Apr 2020	2019	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.